MaaS Global secures substantial funding, Mash introduces a smart payment solution in Spain, Nanoform wins prestigious Pharma Award, and Japanese lifestyle brand MUJI opens its European flagship store in Helsinki. Click on the headlines for more in-depth information about each piece of news.
Finnish mobility-as-a-service pioneer MaaS Global, known for its Whim mobility application, has raised 29.5 million euros in its most recent funding round, participated by both old and new investors. The new investors include BP Ventures, Mitsui Fudosan, Mitsubishi Corporation and Nordic Ninja. The application enables route-planning, booking, ticketing and different payment options with various transport methods, from public transport to taxis and city bikes. MaaS Global now plans to expand to new markets, including in Europe, Japan, Singapore and North America during 2020. Image: MaaS Global
Japanese lifestyle brand MUJI will open its new flagship shop for Europe in the centre of the Finnish capital on 8 November. The 3 400-square-metre shop will occupy an entire floor of Kamppi Shopping Centre and feature MUJI’s first food and restaurant complex in Europe, boasting a selection of Japanese delicacies and local Finnish food from nearly 100 carefully selected small Finnish companies. With its signature no-brand approach, the massive MUJI store will offer up to 7 000 high-quality, reasonably priced products, including a curated book section and the exclusive clothing collection MUJI Labo. Image: Facebook/MUJI
Mash way-to-pay comes to Spain
Finnish fintech company Mash and global payments services provider Ingenico have started a collaboration to bring Mash’s innovative ‘pay later’ solution to merchants across Spain. The solution will allow customers in Spain to defer payment by selecting the Mash payment option from an enabled Ingenico terminal. They will then receive an invoice home with 14 days to choose whether they want to pay for the purchase in full or in instalments. Image: Mash
Nanoform, the Finnish nanotechnology company behind an innovative method to shrink pharmaceutical drugs without changing their properties, has won the Excellence in Pharma Award for Formulation at the CPhI Pharma Awards. Nanoform’s multi-patented nanonisation technology provides novel opportunities for drug delivery and has the ability to raise the number of drug compounds reaching clinical trials by significantly improving dissolution rates and bioavailability. Image: Twitter/Nanoform
Finnish low-carbon solutions aid push for carbon neutrality
Helsinki has a top quality of life